High Content Screening Market By 2016
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>High</strong> <strong>Content</strong> <strong>Screening</strong>: Pharmaceutical and<br />
Healthcare Segment to Remain Dominant Through<br />
2025
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Report Media Releases<br />
<strong>High</strong> <strong>Content</strong> <strong>Screening</strong> <strong>Market</strong> to See Steady Growth, Driven<br />
by Rising Application in Toxicity Studies: PMR Reports<br />
<strong>By</strong> <strong>2016</strong> end, the global high content screening market is likely to register a value of US$<br />
1.24 Bn. In terms of shipment, the consumption of HCS instruments will reach around 555 units<br />
in <strong>2016</strong>. While the pharmaceutical and healthcare segment is expected to register the maximum<br />
consumption of HCS technology and instruments, Western Europe will remain the largest market<br />
in terms of high content screening technology adoption and revenue generation.<br />
Consistent demand for high content screening in order to identify human cell-associated small<br />
molecules, micro-molecules, and peptides, will continue to drive the market for high content<br />
screening globally. Surging biological research and drug discovery activities will also be the<br />
important drivers to the market growth. With growing preference to secondary screening for<br />
toxicity studies, the need for enhanced imaging is also rising, which is considered to be a major<br />
factor boosting the market for high content screening. In addition to burgeoning research in the<br />
field of life science, rising support from governments to research activities will escalate the sales<br />
of HCS instruments.<br />
A Sample of this Report is Available Upon Request @<br />
http://www.persistencemarketresearch.com/samples/12931<br />
Increasing number of biotech and pharmaceutical companies specializing in research is likely to<br />
propel the demand for high content screening technology and devices. A major revenue share<br />
will be contributed by consistent sales of mid-end and high-end HCS instruments. Moreover,<br />
research institutions and educational organizations will also register notable consumption.<br />
Promising emergence of automated cell separation technique and scalability analysis is<br />
anticipated to accelerate market growth further by creating lucrative opportunities for<br />
manufacturers and researchers. Growing need for risks assessment in chronic disease cases is<br />
also considered to be a key factor driving the demand for HCS instruments.<br />
<strong>By</strong> product, the global high content screening market is likely to gain the maximum traction in the<br />
cell imaging and analysis equipment segment. Software segment is expected register a<br />
discernible growth rate.<br />
Based on application, the primary and secondary screening segment will remain dominant with<br />
over 36% market value share, accounting for the revenues of nearly US$ 459.4 Mn in <strong>2016</strong>. With<br />
overall steady growth, this segment is projected to witness a consistently growing Y-o-Y growth<br />
rate post-<strong>2016</strong>. Toxicity studies segment will however exhibit a higher overall growth rate.<br />
Contributing around 17% share to the entire market revenues in <strong>2016</strong>, this segment is<br />
anticipated to exceed a value of US$ 219 Mn. Other application segments include target<br />
identification and validation, compound profiling, and others.<br />
On the basis of end-use, pharmaceutical and healthcare segment will continue its dominance<br />
over biotechnology segment.<br />
<strong>By</strong> regional analysis, Western Europe will remain the largest revenue generator, accounting for<br />
over US$ 424 Mn in terms of revenues. With over 34% market share in <strong>2016</strong>, this segment is<br />
<strong>High</strong> <strong>Content</strong> <strong>Screening</strong> <strong>Market</strong>
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
expected to continue dominance post-<strong>2016</strong>. North America will be the second largest market<br />
with nearly 32% market share in <strong>2016</strong>, followed by Asia Pacific.<br />
Request to View Tables of <strong>Content</strong> @ http://www.persistencemarketresearch.com/marketresearch/high-content-screening-market/toc<br />
Some of the key market players include Becton, Dickinson and Company (BD), Thermo Fisher<br />
Scientific Inc., GE Healthcare, Olympus Corporation, PerkinElmer Inc., Merck Millipore<br />
Corporation, Danaher Corporation (Molecular Devices), Yokogawa Electric Corporation, Sysmex<br />
Corporation and Thorlabs Inc. Key players are increasingly concentrating on developing new,<br />
innovative products for enhanced cell analysis.<br />
To Buy Full Report for a Single User @<br />
http://www.persistencemarketresearch.com/checkout/12931<br />
About Us:<br />
Persistence <strong>Market</strong> Research (PMR) is a third-platform research firm. Our research model is a<br />
unique collaboration of data analytics and market research methodology to help businesses<br />
achieve optimal performance.<br />
<strong>High</strong> <strong>Content</strong> <strong>Screening</strong> <strong>Market</strong>
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
To support companies in overcoming complex business challenges, we follow a multi-disciplinary<br />
approach. At PMR, we unite various data streams from multi-dimensional sources. <strong>By</strong> deploying<br />
real-time data collection, big data, and customer experience analytics, we deliver business<br />
intelligence for organizations of all sizes.<br />
Our offerings include pre-built reports that address every major sale, customized solutions to<br />
cater to client-specific needs, and consulting services to offer more value addition. Our nextgeneration<br />
research approach for exploring emerging technologies has allowed us to solve the<br />
most complex problems of clients. We do not follow a reactive approach, but a pro-active one.<br />
Expert analysts at PMR keep a tab on next-generation technologies in their R&D phase and<br />
provide the latest insights into these technologies when they are being commercialized. Our<br />
ground-breaking approach allows us to deliver market solutions before the technologies reach<br />
the market.<br />
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing<br />
startups. PMR’s collaborative environment is committed to building industry-specific solutions by<br />
transforming data from multiple streams into a strategic asset.<br />
Contact Us:<br />
Persistence <strong>Market</strong> Research<br />
90 Sate Street, Suite 700 Albany, NY 12207<br />
Tel: +1-518-618-1030<br />
Email: sales@persistencemarketresearch.com<br />
Website: http://www.persistencemarketresearch.com/<br />
media@persistencemarketresearch.com<br />
Stay updated with our official Blog: http://pmrblog.com<br />
<strong>High</strong> <strong>Content</strong> <strong>Screening</strong> <strong>Market</strong>